Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 28, 2023

Safety of Switching From a VKA to an NOAC in Older Patients With Atrial Fibrillation and Frailty



Additional Info

Disclosure statements are available on the authors' profiles:

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
Circulation 2023 Aug 27;[EPub Ahead of Print], LPT Joosten, S van Doorn, PM van de Ven, BTG Köhlen, MC Nierman, HL Koek, MEW Hemels, MV Huisman, M Kruip, LM Faber, NM Wiersma, WF Buding, R Fijnheer, HJ Adriaansen, KC Roes, AW Hoes, FH Rutten, GJ Geersing

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading